Iterum Therapeutics Plc (ITRM): ITRM>Development Considerations of An...

Reply Private New

Replies (1) Next 10 Prev Next

Send PM Follow Ignore

Followers	90
Posts	12688
Boards Moderated	4
Alias Born	08/09/2000

swanlinbar

Re: None

Tuesday, 05/17/2022 5:02:56 PM

Tuesday, May 17, 2022 5:02:56 PM

ITRM>Development Considerations of Antimicrobial Drugs for the Treatment of Uncomplicated Urinary Tract Infections (UTI) (Virtual)
JUNE 3, 2022
Scheduled
https://www.fda.gov/drugs/news-events-human-drugs/development-considerations-antimicrobial-drugs-treatment-uncomplicated-urinary-tract-infections-uti?fbclid=IwAR1oTIu8v0UAXGZJuIecyLvsrsb1AZWor3D965NyO2_hzuafLFRtsaOXy1U

"that a rich man is not the one who has the most but the one who needs the least"

Keep Last Read

Replies (1) Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

Detailed Quote

Recent ITRM News

Form 8-K - Current report • Edgar (US Regulatory) • 06/11/2025 11:15:25 AM
Iterum Therapeutics Announces Partnership for Commercialization Services • GlobeNewswire Inc. • 06/11/2025 11:00:00 AM
Iterum Therapeutics Announces Extension of Term of Promissory Note • GlobeNewswire Inc. • 05/19/2025 11:00:00 AM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/13/2025 11:30:25 AM
Form 8-K - Current report • Edgar (US Regulatory) • 05/13/2025 11:15:09 AM
Iterum Therapeutics Reports First Quarter 2025 Financial Results • GlobeNewswire Inc. • 05/13/2025 11:00:00 AM
Iterum Therapeutics to Report First Quarter 2025 Financial Results on May 13, 2025 • GlobeNewswire Inc. • 05/06/2025 11:00:00 AM
Iterum Therapeutics Announces Closing of $5 Million Registered Direct Offering of Ordinary Shares • GlobeNewswire Inc. • 04/30/2025 08:30:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 04/30/2025 01:16:27 AM
Iterum Therapeutics Announces $5 Million Registered Direct Offering of Ordinary Shares • GlobeNewswire Inc. • 04/29/2025 12:00:00 PM
Iterum Therapeutics Presented a Scientific Poster at ECCMID 2025 Highlighting the Impact of Age on Antibiotic Resistance and Efficacy of Antibiotics • GlobeNewswire Inc. • 04/14/2025 12:00:00 PM
Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 03/18/2025 12:00:04 PM
Form 8-K - Current report • Edgar (US Regulatory) • 03/10/2025 12:35:07 PM
Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 02/20/2025 05:15:09 AM
Form 8-K - Current report • Edgar (US Regulatory) • 02/14/2025 09:49:20 PM
Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 02/07/2025 09:33:49 PM
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 02/07/2025 12:30:57 PM
Form 8-K - Current report • Edgar (US Regulatory) • 02/07/2025 12:15:07 PM
Iterum Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results • GlobeNewswire Inc. • 02/07/2025 12:00:00 PM
Iterum Therapeutics to Report Fourth Quarter and Full Year 2024 Financial Results on February 7, 2025 • GlobeNewswire Inc. • 01/31/2025 01:00:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 12/11/2024 11:30:07 AM
Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 12/10/2024 12:04:44 PM
Form 8-K - Current report • Edgar (US Regulatory) • 11/21/2024 02:15:44 PM
Iterum Therapeutics Regains Full Nasdaq Compliance • GlobeNewswire Inc. • 11/21/2024 01:30:00 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2024 12:30:29 PM

More ITRM News

InvestorsHub NewsWire

VAYK to Acquire Up to $9 million in Time-share Vacation Properties Through Non-Cash Deals • VAYK • Jun 11, 2025 9:45 AM

ECGI Holdings Invests in AI-Powered Fantasy Sports Startup Payday Fantasy • ECGI • Jun 10, 2025 8:30 AM

Avant Technologies Signs Letter of Intent for a Business Combination • AVAI • Jun 10, 2025 8:00 AM

NEXT10, Inc. Announces Acquisition of Torreon Group, Inc. • NXTN • Jun 9, 2025 8:42 AM

Maybacks Global Entertainment, LLC and Plex Sign Global Licensing and Distribution Agreement • AHRO • Jun 6, 2025 8:30 AM

Omega Laboratories Delivers Marijuana Breath Test Validation Packet to Cannabix Technologies Inc. - Completing Major Milestone under Strategic Partnership • BLOZF • Jun 5, 2025 8:54 AM

Start posting your company's news

Only $200 per official company press release!

Volume
Day Range:
Bid Price
Ask Price
Last Trade Time:

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Discover

Boards:

Quotes:

Detailed Quote

Recent ITRM News

More ITRM News

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Discover

Boards:

Quotes:

Recent ITRM News

Go Ad-Free